ATAI Life Sciences | 8-K: Current report
ATAI Life Sciences | 8-K: Current report
ATAI Life Sciences | 8-K: atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
ATAI Life Sciences | 8-K: Current report
ATAI Life Sciences | 8-K: Current report
ATAI Life Sciences | 8-K: Current report
ATAI Life Sciences | DEF 14A: Definitive information statements
ATAI Life Sciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition
ATAI Life Sciences | 8-K: atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights
ATAI Life Sciences | 8-K: Current report
ATAI Life Sciences | 8-K: Current report
ATAI Life Sciences | 8-K: Current report
ATAI Life Sciences | 8-K: Current report
ATAI Life Sciences | 8-K: Current report
ATAI Life Sciences | 8-K: atai Life Sciences Reports Third Quarter 2023 Financial Results and Pipeline Highlights
ATAI Life Sciences | 8-K: Current report
ATAI Life Sciences | 8-K: Current report
ATAI Life Sciences | 8-K: Current report
ATAI Life Sciences | 8-K: atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine)
ATAI Life Sciences | 8-K: Current report
No Data
No Data